Related Experiment Videos
Identification of new mutations in primary hyperoxaluria type 1 (PH1)
1Molecular Pathology, University College London, United Kingdom.
Journal of Nephrology
|May 30, 1998
Summary
Primary hyperoxaluria type 1 (PH1), a genetic disorder, results from alanine:glyoxylate aminotransferase (AGT) deficiency. Researchers identified five novel mutations in the AGXT gene in PH1 patients, expanding knowledge of the condition.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- Primary hyperoxaluria type 1 (PH1) is a genetic disorder characterized by the deficiency of the hepatic peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT).
- The AGXT gene, encoding the AGT enzyme, is located on chromosome 2q37.3.
Purpose of the Study:
- To identify novel mutations within the AGXT gene in patients diagnosed with Primary hyperoxaluria type 1.
- To contribute to a comprehensive understanding of the genetic basis of PH1.
Main Methods:
- Single strand conformation polymorphism (SSCP) analysis was employed to screen the AGXT gene.
- Seventy-nine patients with PH1 were analyzed.
Main Results:
- A cluster of new mutations was identified in exon 7 of the AGXT gene.
- Five novel mutations were discovered in exons 2, 4, 5, 9, and 10: T444C, G640A, G690A, 1008-1010delGCG, and G1171A.
Conclusions:
- The identification of these five novel AGXT gene mutations enhances the current knowledge base for PH1.
- The potential impact of these mutations on PH1 phenotype and AGT enzyme activity warrants further investigation.